Not Signed In - Actemra™ Has A Major Impact On Improving Remission Rates In Rheumatoid Arthritis - 3 Studies From The Japanese Phase III Trial Programme
Mon, 13 Nov 2006 08:00 AM EST
... On the 13th November 2006, impressive results will be presented at ACR, the American College of Rheumatology, Washington D. C. These data highlight the outstanding symptom control with Actemra (tocilizumab) monotherapy for patients with rheumatoid arthritis (RA). [click link for full article] ...
Related Topics
- Rheumatoid Arthritis
- Arthritis
- Clinical Trials
- Juvenile Rheumatoid Arthritis
- Rheumatoid Factor
- Rituximab
- Arthritis, Rheumatoid
- Antithrombin III
- Adalimumab
- Septic Arthritis
- Infliximab
- Reactive Arthritis
- Japanese Encephalitis
- Familial Dysautonomia
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Etanercept
- Thalassemia
- Traditional Japanese medicine
- Major depression
email this page
print this page
bookmark this page
feedback on this page
